Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
Condition(s):Peripheral Neuropathic PainLast Updated:June 21, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Peripheral Neuropathic PainLast Updated:June 21, 2022Recruiting
Condition(s):HealthyLast Updated:January 22, 2021Completed
Condition(s):Peripheral Nueropathy PainLast Updated:January 16, 2019Completed
Condition(s):Peripheral Neuropathy PainLast Updated:January 16, 2019Completed
Condition(s):HealthyLast Updated:April 12, 2017Completed
Condition(s):HealthyLast Updated:April 12, 2017Completed
Condition(s):HealthyLast Updated:January 22, 2021Completed
Condition(s):HealthyLast Updated:January 22, 2021Completed
Condition(s):HealthyLast Updated:January 22, 2021Completed
Condition(s):Partial Seizures; Epilepsies, PartialLast Updated:January 25, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.